jKO2fgA0Z5YjoK38l4wA

(SPA, BLRX, SURW) CRWENewswire Stocks In Action

  • 0
  • 0

BioLineRx Ltd BLRX - reported that it has signed a worldwide, exclusive license agreement with Genoscience and RFS Pharma to develop and commercialize BL-8030, an orally available treatment for Hepatitis C.

06 Feb 2012

61 Visualizações

blrx, spa, sparton, surw

Estatísticas do vídeo

Mostrar:

Comentários

Vídeos em Destaque